Medications for Chronic Obstructive Pulmonary Disease (COPD)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Chronic Obstructive Pulmonary Disease (COPD).
Found 26 Approved Drugs for Chronic Obstructive Pulmonary Disease (COPD)
Tiotropium
Brand Names
Spiriva Respimat, Spiriva HandiHaler
Tiotropium
Brand Names
Spiriva Respimat, Spiriva HandiHaler
Form: Spray, Capsule
Method of administration: Respiratory (inhalation), Oral
FDA approval date: October 11, 2005
Classification: Anticholinergic
SPIRIVA HANDIHALER (tiotropium bromide inhalation powder) is indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. SPIRIVA HANDIHALER is indicated to reduce exacerbations in COPD patients. SPIRIVA HANDIHALER is an anticholinergic indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), and for reducing COPD exacerbations ( 1 )
Salmeterol
Brand Names
Salmeterol Diskus, SEREVENT Diskus, Salmeterol HFA, Advair Diskus, Advair HFA, AirDuo RespiClick, Wixela Inhub
Salmeterol
Brand Names
Salmeterol Diskus, SEREVENT Diskus, Salmeterol HFA, Advair Diskus, Advair HFA, AirDuo RespiClick, Wixela Inhub
Form: Aerosol, Powder
Method of administration: Respiratory (inhalation), Oral
FDA approval date: November 25, 1997
Classification: Corticosteroid
Fluticasone propionate and salmeterol inhalation powder is a combination product containing a corticosteroid and a long-acting beta 2 -adrenergic agonist (LABA) indicated for: Twice-daily treatment of asthma in patients aged 4 years and older.
Formoterol
Brand Names
Duaklir Pressair, Perforomist
Formoterol
Brand Names
Duaklir Pressair, Perforomist
Form: Powder, Solution
Method of administration: Respiratory (inhalation)
FDA approval date: October 01, 2007
Classification: beta2-Adrenergic Agonist
Formoterol fumarate inhalation solution is a long-acting beta 2 -adrenergic agonist (beta 2 -agonist) indicated for: Long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Brovana
Generic Name
Arformoterol
Brovana
Generic Name
Arformoterol
Form: Solution
Method of administration: Respiratory (inhalation)
FDA approval date: May 31, 2021
Classification: beta2-Adrenergic Agonist
BROVANA Inhalation Solution is a long-acting beta 2 -adrenergic agonist (beta 2 -agonist) indicated for: Long-term, twice daily (morning and evening) administration in the maintenance treatment of broncho-constriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Glycopyrrolate
Brand Names
Cuvposa, Dartisla Odt, Robinul, Prevduo, Glyrx-Pf, Bevespi, Glycate
Glycopyrrolate
Brand Names
Cuvposa, Dartisla Odt, Robinul, Prevduo, Glyrx-Pf, Bevespi, Glycate
Form: Injection, Aerosol, Tablet, Liquid, Solution
Method of administration: Respiratory (inhalation), Oral, Intravenous, Intramuscular
FDA approval date: February 06, 1975
Classification: Cholinergic Muscarinic Antagonist
In Anesthesia Glycopyrrolate injection is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions; to reduce the volume and free acidity of gastric secretions; and to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation. When indicated, glycopyrrolate injection may be used intraoperatively to counteract surgically or drug- induced or vagal reflexes associated arrhythmias. Glycopyrrolate protects against the peripheral muscarinic effects (e.g., bradycardia and excessive secretions) of cholinergic agents such as neostigmine and pyridostigmine given to reverse the neuromuscular blockade due to non-depolarizing muscle relaxants. In Peptic Ulcer For use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or when oral medication is not tolerated.
Showing 1-5 of 26
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances